A detailed history of Assenagon Asset Management S.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 655,620 shares of EW stock, worth $42.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
655,620
Previous 886,388 26.03%
Holding current value
$42.9 Million
Previous $84.7 Million 28.5%
% of portfolio
0.15%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$84.3 - $94.31 $19.5 Million - $21.8 Million
-230,768 Reduced 26.03%
655,620 $60.6 Million
Q1 2024

Apr 24, 2024

SELL
$72.54 - $95.56 $23.4 Million - $30.8 Million
-322,631 Reduced 26.69%
886,388 $84.7 Million
Q4 2023

Jan 17, 2024

BUY
$61.71 - $77.76 $53.5 Million - $67.4 Million
866,913 Added 253.4%
1,209,019 $92.2 Million
Q3 2023

Nov 06, 2023

BUY
$69.28 - $93.38 $4.92 Million - $6.63 Million
71,028 Added 26.2%
342,106 $23.7 Million
Q2 2023

Jul 25, 2023

SELL
$81.41 - $94.33 $48.5 Million - $56.1 Million
-595,197 Reduced 68.71%
271,078 $25.6 Million
Q1 2023

Apr 18, 2023

BUY
$74.26 - $84.51 $1.21 Million - $1.37 Million
16,266 Added 1.91%
866,275 $71.7 Million
Q4 2022

Jan 12, 2023

BUY
$68.3 - $87.44 $51.8 Million - $66.3 Million
758,715 Added 831.07%
850,009 $63.4 Million
Q3 2022

Oct 27, 2022

BUY
$82.37 - $107.29 $5.36 Million - $6.99 Million
65,114 Added 248.72%
91,294 $7.54 Million
Q2 2022

Jul 27, 2022

BUY
$86.5 - $128.27 $204,399 - $303,102
2,363 Added 9.92%
26,180 $2.49 Million
Q1 2022

Apr 25, 2022

BUY
$101.96 - $128.34 $82,893 - $104,340
813 Added 3.53%
23,817 $2.8 Million
Q4 2021

Feb 01, 2022

BUY
$106.37 - $130.68 $1.61 Million - $1.97 Million
15,090 Added 190.67%
23,004 $2.98 Million
Q3 2021

Oct 19, 2021

BUY
$102.91 - $122.75 $597,907 - $713,177
5,810 Added 276.14%
7,914 $896,000
Q2 2021

Jul 15, 2021

BUY
$83.84 - $104.76 $176,399 - $220,415
2,104 New
2,104 $218,000
Q4 2020

Feb 01, 2021

SELL
$71.69 - $91.23 $816,405 - $1.04 Million
-11,388 Closed
0 $0
Q3 2020

Oct 07, 2020

SELL
$67.19 - $87.44 $119,195 - $155,118
-1,774 Reduced 13.48%
11,388 $909,000
Q2 2020

Jul 21, 2020

SELL
$57.54 - $76.95 $4.34 Million - $5.8 Million
-75,344 Reduced 85.13%
13,162 $910,000
Q1 2020

Apr 17, 2020

BUY
$52.41 - $81.0 $4.58 Million - $7.08 Million
87,411 Added 7982.74%
88,506 $16.7 Million
Q4 2019

Jan 17, 2020

SELL
$71.7 - $82.09 $634,688 - $726,660
-8,852 Reduced 88.99%
1,095 $255,000
Q3 2019

Oct 16, 2019

SELL
$61.55 - $75.43 $12.9 Million - $15.8 Million
-209,670 Reduced 95.47%
9,947 $2.19 Million
Q2 2019

Aug 12, 2019

BUY
$55.74 - $64.41 $12.2 Million - $14.1 Million
219,617 New
219,617 $40.6 Million
Q1 2019

Apr 26, 2019

SELL
$47.89 - $64.05 $833,621 - $1.11 Million
-17,407 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$46.41 - $56.94 $6.94 Million - $8.52 Million
-149,556 Reduced 89.57%
17,407 $2.67 Million
Q3 2018

Oct 29, 2018

BUY
$45.7 - $58.03 $7.63 Million - $9.69 Million
166,963 New
166,963 $29.1 Million
Q2 2018

Jul 17, 2018

SELL
$42.45 - $51.3 $586,701 - $709,017
-13,821 Closed
0 $0
Q1 2018

Apr 30, 2018

BUY
$37.19 - $47.45 $514,002 - $655,806
13,821 New
13,821 $1.93 Million
Q4 2017

Jan 25, 2018

SELL
$33.79 - $39.39 $387,976 - $452,275
-11,482 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$36.29 - $38.83 $416,681 - $445,846
11,482
11,482 $1.26 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.